August 24, 2017
Wilson Therapeutics AB (publ) Interim Report January 1 – June 30, 2017
Media
August 23, 2017
Nordic Nanovector ASA – Results for Second Quarter and First Half Year 2017
August 23, 2017
Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 21, 2017
Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
August 17, 2017
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
August 17, 2017
MIPS: INTERIM REPORT JANUARY – JUNE 2017
August 17, 2017
BONESUPPORT – Q2 2017 Interim Report – invitation to conference call and webcast
August 16, 2017
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2017 (UNAUDITED)
August 15, 2017
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 22 NOVEMBER 2017
August 14, 2017
Invitation to second quarter and first half 2017 results presentation Thursday 24 August
